| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles |
Presented in part at the 63rd to 66th Scientific Sessions of the American Heart Association (1990-1993).
From the Department of Cardiology, University of Heidelberg (Germany).
Correspondence to Dr Feraydoon Niroomand, Universität Heidelberg, Innere Medizin III, Bergheimerstr 58, 69115 Heidelberg, Germany.
Abstract A brief antecedent period of myocardial
ischemia and reperfusion can delay cellular injury during a subsequent
ischemic condition. Recent observations suggest that this protective
mechanism depends on the continued activation of adenosine
A1 receptors and Gi proteins. During acute
myocardial ischemia, sufficient amounts of adenosine for maximal
activation of adenosine A1 receptors are
released, independent of a preconditioning ischemia. Hence, the
protective mechanism of ischemic preconditioning may not exclusively be
explained by activation of adenosine A1 receptors. As a
working hypothesis, an increased responsiveness of Gi
proteins toward receptor-mediated activation, leading to an increased
response of Gi-regulated effectors, was tested in this
study. In 47 anesthetized dogs, ischemia was induced by proximal
ligation of the left anterior descending coronary artery. Animals
underwent either a single period of 5 minutes of ischemia (n=9), a
single period of 15 minutes of ischemia (n=10), 5 minutes of ischemia
followed by 15 minutes of reperfusion (n=8), 15 minutes of ischemia
followed by 60 minutes of reperfusion (n=5), or 5 minutes of ischemia
followed by 15 minutes of reperfusion and a second period of 5 minutes
of ischemia (n=15). Sarcolemmal membranes were prepared from the
central ischemic area and from the posterior left ventricular wall,
which served as the control. During ischemia, carbachol-stimulated
GTPase decreased by 38% (control, 33.5±17.7; ischemia, 24.2±15
pmol · min-1 · mg protein-1; n=9;
P<.001). The decrease in carbachol-stimulated GTPase
activity was associated with a 45% decrease in carbachol-mediated
inhibition of adenylyl cyclase (control, 28.9±2.4% maximal
inhibition; ischemia, 15.1±2.6% maximal inhibition; n=5;
P<.001). Prolongation of the ischemic period to 15 minutes
did not lead to a further reduction of the Gi-mediated
signal transduction. The binding properties of muscarinic receptors
were not affected by ischemia. Furthermore, as demonstrated by
carbachol-stimulated binding of [
-35S]GTP to
sarcolemmal membranes, high- and low-affinity binding sites for the
muscarinic antagonist carbachol, the EC50 for
carbachol-stimulated GTPase activity and the substrate dependency of
the high-affinity GTPase, the interaction between muscarinic receptors
and inhibitory G proteins, and GTP binding to G proteins were not
altered (n=14). Immunoblotting with
i- and
i2-specific antibodies did not indicate a loss of
Gi proteins during ischemia that could
explain the reduced GTPase activity. During 15 minutes of
reperfusion, carbachol-stimulated GTPase activity increased to 147% of
the control value (control, 33.7±20.6; reperfusion, 49.1±22.5
pmol · min-1 · mg protein-1; n=7;
P=.012). Maximal inhibition of adenylyl cyclase by carbachol
increased similarly (control, 21±6.8% maximal inhibition;
reperfusion, 26.4±7.6% maximal inhibition; n=8; P=.016).
After 15 minutes of ischemia and 60 minutes of reperfusion,
carbachol-stimulated GTPase activity remained increased. When the
5-minute ischemia and 15-minute reperfusion periods were followed by a
second period of 5-minute ischemia, carbachol-stimulated GTPase
activity and inhibition of adenylyl cyclase remained elevated (GTPase:
control, 38.4±16.7; second ischemia, 49.2±20.1
pmol · min-1 · mg protein-1; n=13;
P=.009; adenylyl cyclase: control, 24.2±6.8% maximal
inhibition; second ischemia, 28.6±8% maximal inhibition; n=15;
P=.003). In conclusion, the responsiveness of Gi
proteins toward receptor activation decreased rapidly during the first
5 minutes of ischemia. During a following 15-minute period of
reperfusion, this decreased responsiveness was reversed completely,
exceeding control activities. The increased responsiveness of this
signaling pathway was maintained during a subsequent second ischemic
period. This suggests that the underlying mechanism of ischemic
preconditioning is the increased responsiveness of Gi
proteins after a brief period of ischemia and reperfusion.
Key Words: myocardial ischemia reperfusion ischemic preconditioning G proteins muscarinic receptors adenylyl cyclase
This article has been cited by other articles:
![]() |
S. Tommasi, E. Carluccio, M. Bentivoglio, L. Corea, and E. Picano Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris: A double-blind, placebo controlled crossover stress echocardiographic study J. Am. Coll. Cardiol., January 1, 2000; 35(1): 83 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. J. Schultz, A. K. Hsu, J. T. Barbieri, P.-L. Li, and G. J. Gross Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H495 - H500. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Domenech, P. Macho, D. Velez, G. Sanchez, X. Liu, and N. Dhalla Tachycardia Preconditions Infarct Size in Dogs : Role of Adenosine and Protein Kinase C Circulation, March 3, 1998; 97(8): 786 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mizumura, J. A. Auchampach, J. Linden, R. F. Bruns, and G. J. Gross PD 81,723, an Allosteric Enhancer of the A1 Adenosine Receptor, Lowers the Threshold for Ischemic Preconditioning in Dogs Circ. Res., September 1, 1996; 79(3): 415 - 423. [Abstract] [Full Text] |
||||
![]() |
H. Miyawaki, X. Zhou, and M. Ashraf Calcium Preconditioning Elicits Strong Protection Against Ischemic Injury via Protein Kinase C Signaling Pathway Circ. Res., July 1, 1996; 79(1): 137 - 146. [Abstract] [Full Text] |
||||
![]() |
R. Sandhu, U. Thomas, R. J. Diaz, and G. J. Wilson Effect of Ischemic Preconditioning of the Myocardium on cAMP Circ. Res., January 1, 1996; 78(1): 137 - 147. [Abstract] [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |